Marc Lerchenmüller

Marc Lerchenmüller serves as Assistant Professor of Technological Innovation and Management at the University of Mannheim Business School and maintains an active affiliation with the Center for European Economic Research (ZEW). His work bridges academic research with practical applications in innovation systems and science policy, emphasizing economic incentives and knowledge translation.

His educational background spans five elite institutions:

• Imperial College London
• London School of Hygiene and Tropical Medicine
• Oxford University
• WHU
• Yale University

Lerchenmüller's research centers on the economics of innovation and science policy, with dual focus areas: (1) how monetary incentives shape strategic decisions in innovative sectors, and (2) the impact of non-ability factors like gender and social conditions on research careers. His investigations into the gender gap in science examine longitudinal effects on publication patterns and career trajectories, revealing systemic inequities with century-long implications.

Analysis of his recent publications shows consistent emphasis on quantitative assessment of scientific ecosystems, particularly gender disparities in cardiovascular and pandemic-related research alongside emerging trends in AI-driven life science innovation. This work combines bibliometric analysis with policy-relevant insights for research funding bodies.

Professor Lerchenmüller has secured competitive third-party funding from major organizations including:

• German Research Foundation (DFG)
• German Academic Exchange Service (DAAD)
• Helmholtz Association

He serves on international scientific advisory boards, notably providing expertise to the European Commission on the impact of the Covid crisis on science. Beyond academia, Lerchenmüller co-founded biotechnology startup InoCard (acquired by uniQure in 2014) and currently leads gene therapy venture AaviGen, demonstrating his commitment to translating research into real-world applications.